Live Breaking News & Updates on Regeneron Facebook

Dr. George Yancopoulos, the Mind Behind Regeneron’s Covid Treatment
” width=”684″>
Dr. George Yancopooulos and Dr. Leonard Schleifer of Regeneron at company headquarters in New York. Credit: Regeneron/Facebook
Dr. George Yancopoulos is the CEO of Regeneron, maker of one of two experimental therapies for the treatment of “mild to moderate” cases of Covid-19 that was authorized by the US’ Food and Drug Administration.
George Yancopoulos is the founding scientist and Chief Scientific Officer of Regeneron Pharmaceuticals, working alongside Founder and Chief Executive Officer Leonard Schleifer, M.D. In 2016, Yancopoulos was also named President of Regeneron.
George Yancopoulos and Regeneron ....

New York , United States , Westchester County , Columbia University , Leonard Schleifer , Regeneron Facebook , George Yancopooulos , Georged Yancopoulos Young , Lucillep Markey , George Yancopoulos , Regeneron Pharmaceuticals , Columbia College , Columbia University Stevens Triennial Prize For Research , Human Services , Regeneron Genetics Center , Drug Administration , American Academy Of Arts , National Academy Of Sciences , Institute For Scientific Information , Bronx High School Of Science , National Award Winners , Columbia University College Of Physicians Surgeons , Department Of Health , University Medal Of Excellence , Chief Scientific Officer , Chief Executive Officer Leonard Schleifer ,